NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









N-Power Medicine

N-Power Medicine

Private
Redwood City, CaliforniaHealthcare & Life Scienceshttps://www.npowermedicine.com/

Last Round

Strategic

Dec 30, 2024

Total Funding Raised

$85M

Company Overview

N-Power Medicine is a biotechnology company that provides an AI-enabled clinical research platform to accelerate oncology drug development by integrating research workflows into community oncology practices.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Precision Medicine, Healthcare Analytics, Data Integration

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

external control armProECAclinical trial accelerationreal-world dataRWDprecision medicineclinical data integrationoncology researchpoint-of-care platformclinical trial softwaresynthetic control armchart review automationhuman-in-the-loopdata as a serviceDaaSclinical workflow automation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

N-Power Medicine Comps

Public and private peers based on sector, stage, and business model.

N-Power Medicine comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

N-Power Medicine Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicDec 30, 2024
Series BJul 1, 2024

Key People

Founding team and executive leadership

Mark Lee

CEO & Co-Founder

Founding Team

Soo Bang

Corporate Business Development & Strategic Advisor to CEO

Executive Team

Joel Smith

Chief Financial Officer

Executive Team

N-Power Medicine Investors

Notable investors and investment history

N-Power Medicine investors
InvestorRounds
Innovatus Capital PartnersStrategic

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 19, 2025

    Launched industry-first Prospective External Control Arm platform for oncology drug development.

  • May 19, 2025

    Generating revenue from a growing base of BioPharma customers.

N-Power Medicine Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

N-Power Medicine Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about N-Power Medicine's valuation, stock price, and market status.

Firmographic Details

HeadquartersRedwood City, California
Employee Range120
Year Founded2021
Last FundingDec 30, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.